22 Generic Product Launches So Far in 2023

Camber is pleased to announce that 22 new generic products were added to the company’s portfolio in the last 6 months! The organization expects launches to accelerate in the second half of 2023.

  • Naproxen Sodium Tablets (generic for Aleve®)
  • Promethazine HCI Suppositories, USP (generic for Phenergan®)
  • Trientine Hydrochloride Capsules, USP (generic for Syprine®)
  • Posaconazole DR Tablets (generic for Noxafil®)
  • Ezetimibe Tablets (generic for Zetia®)
  • Roflumilast 250 mcg Tablets (generic for Daliresp®)
  • Zileuton ER Tablets (generic for Zyflo CR®)
  • Valganciclovir for Oral Solution (generic for Valcyte®)
  • Ranolazine ER Tablets (generic for Ranexa®)
  • Linezolid for Oral Suspension (generic for Zyvox®)
  • Levothyroxine Sodium Tablets, USP (generic for Thyro-Tabs®)
  • Pantoprazole Sodium for Injection (generic for Protonix®)
  • Aminocaproic Acid Oral Solution, USP (generic for Amicar®)
  • Teriflunomide Tablets (generic for Aubagio®)
  • Diclofenac Potassium Oral Solution (generic for Cambia®)
  • Sapropterin Dihydrochloride PFOS (generic for Kuvan® OS)
  • Sapropterin Dihydrochloride Tablets (generic for Kuvan®)
  • Deferasirox Oral Granules (generic for Jadenu® Sprinkle)
  • Memantine HCl Tablets (generic for Namenda®)
  • Vancomycin HCl Injection
  • Mexiletine HCl Capsules (generic for Mexitil®)
  • Daptomycin for Injection, 350 mg/Vial (of Sagent Pharmaceuticals)

Contact your Camber representative to learn more about these exciting launches and future opportunities.